Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$113.48 USD
-0.43 (-0.38%)
Updated Jan 17, 2025 04:00 PM ET
After-Market: $113.69 +0.21 (0.19%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 31% (77 out of 250)Zacks Sector Rank
Top 6% (1 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.58 | 1.70 | 9.99 |
Current Quarter Estimate | 1.34 | 7.55 | 61.00 |
Year Ago Quarter Estimate | 1.19 | 5.05 | 53.90 |
Next Quarter Estimate | 1.12 | 7.44 | NA |
Next Year Estimate | 5.14 | 44.06 | 277.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 5.18 | 11.90 | 12.40 |
Next Year | 10.06 | 19.80 | 15.25 |
Last 5 Years | 9.00 | 4.90 | 8.10 |
Next 5 Years | 9.10 | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 25.11 | -1.12 |
Price/Book (MRQ) | 4.92 | 1.76 |
Price/Cash Flow (MRFY) | 17.84 | 11.83 |
Dividend Yield | 2.08% | 0.00% |
Net Profit Margin (TTM) | 13.99% | -52.12% |
Return on Equity (TTM) | 20.18% | 8.34% |
Debt to Equity (MRQ) | NA | 29.28 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.